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disorders, including phenylketonuria, 
cystic fibrosis, and sickle cell disease. In 
the United States, most of the XPC muta-
tions identified to date have been found 
in one or a small number of families 
without a founder mutation (Khan et al., 
2006). High frequency of an XP found-
er mutation in other parts of the world 
makes genetic screening by DNA analy-
sis feasible. Early diagnosis and insti-
tution of sun protection measures are 
essential for preventing skin cancer and 
preserving vision in patients with XP, 
and early detection can save lives. Thus, 
it is reasonable to consider newborn 
screening for XP in selected popula-
tions with a high frequency of a founder 
mutation. Similarly, premarital screening 
for the presence of the founder mutation 
may be a part of genetic counseling. The 
founder mutation also may be used for 
prenatal diagnosis in pregnancies where 
the parents are carriers.
clinical phenotype of XP patients  
with founder mutation
Most African patients with XPC with 
the delTG mutation in both alleles have 
similar clinical features consisting of 
photosensitivity, pigmentary changes, 
and early onset of skin cancer without 
neurological involvement (Mahindra 
et al., 2008; Ben et al., 2009; Soufir et 
al., 2010). However, two patients were 
reported to be homozygous for the 
delTG but with neurological involve-
ment (Soufir et al., 2010). This is similar 
to XP-C patients reported with homozy-
gous mutations in the initiation codon 
with and without neurological involve-
ment (Khan et al., 2009). These data 
suggest that neurological involvement 
may be caused by consanguinity with 
homozygosity of other unknown genes 
or by modifying genes or prenatal expo-
sure to teratogens or infectious agents. 
The data also point to possible problems 
in trying to predict phenotype when only 
the genotype is known.
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cross-Talk between 
Hemidesmosomes and Focal 
contacts: Understanding 
Subepidermal Blistering Diseases
Yasuo Kitajima1
Because hemidesmosomes and focal contacts (Fcs) play major roles in epi dermal 
wound healing and in the pathogenesis of subepidermal blistering diseases, it is 
of particular importance to understand their cross-talk in the regulation of their 
assembly and disassembly. In this issue, Ozawa et al. demonstrate that hemides-
mosome-enriched protein complex (HPc) and Fc dynamics are tightly coregulat-
ed in keratinocytes undergoing migration by employing Hacat cells that express 
fluorescent protein–tagged β4 integrin and α-actinin as markers of HPcs and Fcs.
Journal of Investigative Dermatology (2010) 130, 1493–1496. doi:10.1038/jid.2010.77
Keratinocytes adhere to the basement 
membrane (BM) through two major 
protein complexes: keratin-associated 
hemidesmosomes and actin-associated 
focal contacts (FCs), both of which bind 
to the BM mainly through laminin-332 
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(Ln-332). Hemidesmosomes consist 
of three single-span transmembrane 
proteins, namely, the bullous pemphi-
goid antigen 180 (PB180) known as 
type XVII collagen, α6 and β4 inte-
grins (Jones et al., 1998), and a tetra-
span transmembrane protein, CD151 
(tetraspanin) (Sterk et al., 2000). The 
cytoplasmic aspects of these three 
adhesion molecules are associated with 
at least two intracellular proteins—
BP230 and plectin—which are mem-
bers of the plectin family of proteins. 
Plectin, which has diverse binding 
activities, binds to keratin intermediate 
filaments (Jones et al., 1998). CD151 
is associated with integrins and medi-
ates outside-in signaling by interact-
ing with integrins at hemidesmosomes 
(Sterk et al., 2000). On the other hand, 
FCs are composed mainly of α3β1 and 
α2β1 integrins, which are associated 
with a variety of structural/signaling 
mole cules, including α-actinin, vincu-
lin, talin, paxillin, and focal adhesion 
kinase, many of which are linked to 
actin and microtubule cytoskeletons 
(Mitra et al., 2005).
The important role of hemides-
mosomes in epidermal cell adhe-
sion to the BM has been learned in 
studies of patients with junctional 
epidermolysis bullosa (JEB), includ-
ing a nonlethal variant, generalized 
atrophic benign EB (GABEB), which 
is caused by mutations in the BP180 
gene (Jonkman et al., 1995); epider-
molysis bullosa (EB) with pyloric atre-
sia, which is caused by mutations in 
the α6β4 integrin (Pulkkinen et al., 
1998); and EB simplex, caused by 
plectin gene mutations (Pfendner and 
Uitto, 2005). CD151 gene mutations 
also cause a rare form of EB, pretibial 
EB with hereditary nephritis, suggest-
ing that CD151 is involved in dermal–
epidermal adhesion, although its func-
tion in hemidesmosomes is not clear 
(Karamatic Crew et al., 2004). Bullous 
pemphigoid, a subepidermal blister-
ing disease caused by autoantibodies 
against BP180, also suggests a substan-
tial role for BP180 in basal cell adhe-
sion to the BM because pathogenic 
autoantibodies against BP180 decrease 
BP180 in hemidesmosomes, resulting 
in a reduction in the strength of kera-
tinocytes’ adhesion to matrix (Iwata 
et al., 2009).
Kindler syndrome, a rare genetic 
disorder characterized by skin fragility 
and photosensitivity, includes neonatal 
acral blistering, skin atrophy, dyspig-
mentation, nail dystrophy, and digital 
webbing. This disorder demonstrates 
the importance of FCs in the adhe-
sion of basal cells to the BM because 
the disease is caused by a mutation in 
Kindlin-1, an FC-associated signaling 
protein, and fermitin family homo-
logue 1 (FFH1), which plays a role in 
linking the actin cytoskeleton to the 
extracellular matrix at FCs. Consistent 
with this, keratinocytes from patients 
with Kindler syndrome and Kindlin-
1-depleted keratinocytes demonstrate 
impaired cell adhesion and spreading 
(Herz et al., 2006).
Most of the abovementioned diseas-
es show bullous skin lesions with adja-
cent dyspigmentation, atrophy, and 
scarring after healing of the resulting 
skin erosions. It is of particular interest 
to note that there are subtle but signifi-
cant differences in the clinical char-
acteristics of the skin following blister 
healing, because these differences 
might reflect distinct modes of wound 
healing (i.e., re-epithelialization is 
thought to be regulated by FCs and 
hemidesmosome dynamics). Thus, it is 
tempting to speculate that gene muta-
tions in the different molecules that 
compose FCs and hemidesmosomes 
may generate a variety of abnormal 
cross-talk signals between hemidesmo-
somes and FCs during cell migration, 
resulting in the formation of subtle but 
significant differences in skin surface 
characteristics after blister healing. It is 
noteworthy that the article by Ozawa 
et al. (2010, this issue) demonstrates 
an energy-dependent dynamic rela-
tionship between FCs and hemides-
mosome-enriched protein complexes 
(HPCs), which are adhesion structures 
in cultured keratinocytes equivalent to 
the hemidesmosomes observed during 
re-epithelialization in vivo.
The dynamic interrelationship 
between FCs and HPCs described by 
Ozawa et al. (2010) reminds me of 
the cross-talk between actin-associ-
ated adherens junctions and keratin-
associated desmosomes at points of 
cell–cell adhesion. Like plakoglobin, 
which localizes to both adherens junc-
tions and desmosomes and is thought 
to participate in cross-talk between 
adherens junctions and desmosomes 
(Yin and Green, 2004), plectin, which 
binds to both F-actin and keratin inter-
mediate filaments, may mediate com-
munication between FCs and hemi-
desmosomes. CD151 is also expected 
to be involved in FC–hemidesmosome 
cross-talk because CD151 not only 
associates with integrin α3β1 to form 
FCs and with integrin α6β4 to stabi-
lize hemidesmosomes (Litjens et al., 
2006) but also plays a signaling role 
in forming the hemidesmosome(s) 
behind FCs.
Ozawa et al. (2010) also demon-
strate that HPCs’ perturbation (induced 
with anti-α6 and β4 integrin antibodies, 
keratin filament disruption, and plectin 
or CD151 knockdown) causes more 
rapid FC movement and a reduction in 
FC size during re-epithelialization, sug-
gesting that FC movement is regulated 
by HPCs. Surprisingly, in an epidermal-
specific desmoplakin-knockout mouse 
model of desmosomes that lack 
keratin intermediate filament–binding, 
adherens junctions are also reduced, 
clinical Implications
•  Gene mutations in the different molecules that compose focal 
contacts and hemidesmosomes may generate different abnormal 
cross-talk signals during cell-migration and wound healing.
•  The clinical characteristics of skin following healing may reflect 
unique modes of wound-healing associated with each genetic 
blistering disorder.
•  Unraveling the diverse genetic errors in focal contact/
hemidesmosomal cross-talk that cause blistering may lead  
to gene-specific treatments for the erosions that follow  
dermal-epidermal separation.
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suggesting that desmosomes cross-talk 
with adherens junctions through actin 
filament o rganization (Vasioukhin 
et al., 2001). Ozawa et al. also demon-
strate that FC destabilization, caused 
by anti-α3 integrin antibodies and 
the actin filament depolymerizing 
drug cytochalasin D, reduce the HPC 
dynamics and size and perturb HPC 
assembly. As such, there is a similarity 
in terms of cross-talk between adherens 
junctions and desmosomes: deletion of 
E-cadherin and P-cadherin causes loss 
of adherens junctions in keratinocytes 
and perturbs the recruitment of the 
desmosomal molecules, desmoplakins, 
plakophilin-3 desmogleins, and pla-
koglobin within 48 hours after Ca2+ 
switch, suggesting that adherens junc-
tion components control desmosome 
formation (Michels et al., 2009).
The function(s) of CD151 in kera-
tinocyte movement should be moni-
tored with keen interest because it 
binds directly to integrin α6β4 at 
hemidesmosomes, providing hemi-
desmosome stability during wound re-
epithelialization (Kopecki et al., 2009). 
In addition, in contrast to the results by 
Ozawa et al. (2010), CD151-deficient 
mice show impaired wound healing, 
whereas CD151-deficient A431 cells 
display impaired motility (Kopecki et 
al., 2009). In this regard, it is of interest 
that CD151 expression in the epi-
dermis of wild-type mice is increased 
in response to wounding, peaking at 
day 3, when cell migration is expected 
to be activated, and decreasing by day 
7 after wounding (Kopecki et al., 2009). 
In either case, CD151 appears to be a 
major player in the communication 
between FCs and hemidesmosomes. 
Thus, important clues for complete 
understanding of the role of CD151 
may be concealed under the complex-
ity of CD151 functions in cross-talk 
between hemidesmosomes and FCs 
during re-epithelialization.
The dynamic live-cell analysis per-
formed by Ozawa et al. (2010) reveals 
that FCs contribute to cell spreading 
and migration, whereas hemidesmo-
somes form stable anchorage of kera-
tinocytes to maintain a migrating direc-
tion during wound healing. Inhibition 
of HPC assembly in HaCat cells with 
antibodies against α6 integrin, β4 inte-
grin, and BP180 perturbs directional 
cell migration but causes random 
migration. The same cell behavior was 
generated with disruption of the kera-
tin filament network by transfecting 
a keratin 14 deletion mutant plasmid 
into HaCat cells. Together, these find-
ings suggest that HPCs limit the range 
in which FCs can be newly assembled, 
possibly by actin, and through plectin 
and/or signaling mediated by CD151, 
which can bind to both FCs (integ-
rin α3β1) and HPCs (integrin α6β4). 
After new FCs are formed within the 
range of a group of HPCs, new HPCs 
are then assembled just behind the 
new FCs, which are in turn disassem-
bled to form an additional row of FCs 
at the front edge of a new range lim-
ited by new HPCs (Figure 1). Thus, it is 
tempting to imagine that cells migrate 
in a fashion akin to that of a caterpil-
lar, which swings its head in the migra-
tion direction to find a new spot at 
which to initiate the subsequent steps, 
all within a range limited by the posi-
tion of its rear legs (holding onto a 
twig). This leads to speculation that 
the clinical differences in scar appear-
ance of poikiloderma between GABEB 
and Kindler syndrome may derive 
from different wound healing mecha-
nisms resulting from impaired cross-
talk due to incorrect “messages” from 
BP180-deficient hemidesmosomes 
and FFH1-impaired focal contacts, 
respectively.
It is of particular interest that Ozawa 
et al. (2010) used live-image analysis 
to demonstrate the energy and myosin 
dependency of the dynamic inter-
actions between HPCs and FCs in 
migrating keratinocytes. These live-
image results create an expectation 
of a more profound understanding of 
the regu latory mechanisms involved 
in the dynamic cross-talk between 
FCs and HPCs (i.e., hemidesmo-
somes). Such analyses may provide 
new clues and methods to unravel 
the blistering mechanisms behind the 
hemidesmosome, as well as novel 
treatments for erosions generated by 
dermal–epidermal separation.
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The Other end of the Rainbow: 
Infrared and Skin
Aton M. Holzer1, Mohammad Athar1 and Craig A. Elmets1
Although infrared radiation (IRR) is ubiquitous in the terrestrial milieu, its 
effects on human skin have until now been largely ignored. Recent studies 
suggest an important role for infrared A (IRA) radiation (760–1440 nm) in 
dermal inflammation, photoaging, and photocarcinogenesis. In this issue, 
calles et al. identify and analyze the IRA-induced transcriptome in human 
dermal fibroblasts. Their work paves the way for new research directions in 
IRA photobiology and raises important clinical questions regarding photo-
protection and IRR-based dermatotherapy.
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Introduction
The refraction of light into its constitu-
ent colors was first described in the 
eleventh century by the scientist and 
polymath Ibn al-Haytham (Alhacen) 
and was fully developed in Sir Isaac 
Newton’s description of the electro-
magnetic spectrum in 1671. In 1800, 
astronomer William Herschel pub-
lished his discovery of “calorific rays” 
beyond the red part of the visible spec-
trum. He found that refraction of light 
through a prism separated out a set 
of electromagnetic rays—later known 
as infrared radiation (IRR)—that pro-
duced an increase in temperature on a 
thermometer beyond that recorded in 
the visible spectrum (Mahmoud et al., 
2008). Although IRR has been known 
to science for 210 years (1 year longer 
than has UVR), the impact of IRR on 
cutaneous pathology has received far 
less attention than its UV and visible 
counterparts. With the publication of 
the study by Calles and co-workers 
(2010, this issue), this may begin to 
change. These investigators exposed 
human dermal fibroblasts to infra-
red A (IRA) radiation and analyzed 
the IRA-induced transcriptome using 
microarray technology. The changes 
observed differed in several respects 
from those induced by UVR, and 
Calles et al. identified a number of 
candidate genes that could contribute 
to photoaging and carcinogenesis.
Unna (1894) first described a pho-
todistributed dermatosis in sailors 
that he called Seemanshaut, a local-
ized photoaging that he attributed to 
prolonged sun exposure. Early in the 
following century, Hyde (1906) and 
Dubreuilh (1907) published the first 
evidence linking human skin can-
cer to sunlight. Subsequent studies 
in mice isolated wavelengths in the 
ultraviolet spectrum (280–400 nm)—
in particular, within UVB (280–320 
nm)—as most proficient in causing 
nonmelanoma skin cancer (Findlay, 
1928; Freeman, 1978). As such, pho-
toprotection strategies have focused 
almost exclusively on limiting expo-
sure to UVB and, increasingly, to UVA 
(320–400 nm).
Nonetheless, UVR constitutes only 
7% of the solar energy that reaches 
the skin; 39% lies in the visible light 
spectrum (400–760 nm). But the most 
considerable fraction of solar ener-
gy (54%) consists of IRR (Kochevar 
et al., 1999), which comprises IRA 
(760–1440 nm), IRB (1440–3000 nm), 
and IRC (3000 nm–1 mm). Of these, 
only IRA—30% of the IRR that reaches 
the human body—penetrates deeply 
into the skin, and 65% of that portion 
reaches the dermis (Schroeder et al., 
2010). Thus, IRA is well positioned to 
exert effects at that level.
Infrared radiation in clinical and 
experimental dermatology
Until recently, chronic exposure to 
IRR (when administered below the 
threshold for inducing thermal injury) 
was recognized as the cause of only 
one skin disorder, erythema ab igne, 
